APOE and Alzheimer disease: Peripheral inflammation, such as changes in cytokine and chemokine levels as well as activated immune cells, is linked to AD-relevant pathology and behavior in AD-relevant mouse models including with APOE4 (Benicky et al., 2009; Marottoli et al., 2017).